Literature DB >> 20192806

Differentiation of effector CD4 T cell populations (*).

Jinfang Zhu1, Hidehiro Yamane, William E Paul.   

Abstract

CD4 T cells play critical roles in mediating adaptive immunity to a variety of pathogens. They are also involved in autoimmunity, asthma, and allergic responses as well as in tumor immunity. During TCR activation in a particular cytokine milieu, naive CD4 T cells may differentiate into one of several lineages of T helper (Th) cells, including Th1, Th2, Th17, and iTreg, as defined by their pattern of cytokine production and function. In this review, we summarize the discovery, functions, and relationships among Th cells; the cytokine and signaling requirements for their development; the networks of transcription factors involved in their differentiation; the epigenetic regulation of their key cytokines and transcription factors; and human diseases involving defective CD4 T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192806      PMCID: PMC3502616          DOI: 10.1146/annurev-immunol-030409-101212

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  310 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.

Authors:  G Cai; T Radzanowski; E N Villegas; R Kastelein; C A Hunter
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

3.  Requirement for RORgamma in thymocyte survival and lymphoid organ development.

Authors:  Z Sun; D Unutmaz; Y R Zou; M J Sunshine; A Pierani; S Brenner-Morton; R E Mebius; D R Littman
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

4.  GATA3 haplo-insufficiency causes human HDR syndrome.

Authors:  H Van Esch; P Groenen; M A Nesbit; S Schuffenhauer; P Lichtner; G Vanderlinden; B Harding; R Beetz; R W Bilous; I Holdaway; N J Shaw; J P Fryns; W Van de Ven; R V Thakker; K Devriendt
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

5.  Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; W E Paul; A Sher
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 6.  The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.

Authors:  J X Lin; W J Leonard
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

7.  An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells.

Authors:  J A Hural; M Kwan; G Henkel; M B Hock; M A Brown
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

8.  Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo.

Authors:  S Agarwal; O Avni; A Rao
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

9.  Stat6 regulation of in vivo IL-4 responses.

Authors:  F D Finkelman; S C Morris; T Orekhova; M Mori; D Donaldson; S L Reiner; N L Reilly; L Schopf; J F Urban
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

10.  GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells.

Authors:  H J Lee; N Takemoto; H Kurata; Y Kamogawa; S Miyatake; A O'Garra; N Arai
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  1301 in total

1.  Alternatively activated dendritic cells regulate CD4+ T-cell polarization in vitro and in vivo.

Authors:  Peter C Cook; Lucy H Jones; Stephen J Jenkins; Thomas A Wynn; Judith E Allen; Andrew S MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-01       Impact factor: 11.205

2.  Rapamycin Prolongs Graft Survival and Induces CD4+IFN-γ+IL-10+ Regulatory Type 1 Cells in Old Recipient Mice.

Authors:  Markus Quante; Timm Heinbokel; Karoline Edtinger; Koichiro Minami; Hirofumi Uehara; Yeqi Nian; Haruhito Azuma; Reza Abdi; Abdallah Elkhal; Stefan G Tullius
Journal:  Transplantation       Date:  2018-01       Impact factor: 4.939

Review 3.  Molecular regulation of effector and memory T cell differentiation.

Authors:  John T Chang; E John Wherry; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

4.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Robin Kageyama; Danelle Eto; Tania C Escobar; Robert J Johnston; Laurel Monticelli; Christopher Lao; Shane Crotty
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

5.  Rapid HIV Progression Is Associated with Extensive Ongoing Somatic Hypermutation.

Authors:  Ben S Wendel; Yajing Fu; Chenfeng He; Stefany M Hernandez; Mingjuan Qu; Zining Zhang; Yongjun Jiang; Xiaoxu Han; Junjie Xu; Haibo Ding; Ning Jiang; Hong Shang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 6.  An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation.

Authors:  Ryoji Yagi; Jinfang Zhu; William E Paul
Journal:  Int Immunol       Date:  2011-06-01       Impact factor: 4.823

7.  IL-6 receptor α defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthma.

Authors:  Naeun Lee; Sungyong You; Min Sun Shin; Won-Woo Lee; Ki Soo Kang; Sang Hyun Kim; Wan-Uk Kim; Robert J Homer; Min-Jong Kang; Ruth R Montgomery; Charles S Dela Cruz; Albert C Shaw; Patty J Lee; Geoffrey L Chupp; Daehee Hwang; Insoo Kang
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

8.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

9.  Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.

Authors:  William L Redmond; Stefanie N Linch; Melissa J Kasiewicz
Journal:  Cancer Immunol Res       Date:  2013-11-11       Impact factor: 11.151

10.  CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy.

Authors:  Hong Chen; Tihui Fu; Woong-Kyung Suh; Dimitra Tsavachidou; Sijin Wen; Jianjun Gao; Derek Ng Tang; Qiuming He; Jingjing Sun; Padmanee Sharma
Journal:  Cancer Immunol Res       Date:  2013-11-19       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.